3,4,5-TRIHYDROXYBENZAMIDOXIME

Details

Stereochemistry	ACHIRAL
Molecular Formula	C7H8N2O4
Molecular Weight	184.1494
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of 3,4,5-TRIHYDROXYBENZAMIDOXIME

Structure Search

SMILES

ONC(=N)C1=CC(O)=C(O)C(O)=C1

InChI

InChIKey=MSLJYSGFUMYUDX-UHFFFAOYSA-N

InChI=1S/C7H8N2O4/c8-7(9-13)3-1-4(10)6(12)5(11)2-3/h1-2,10-13H,(H2,8,9)

HIDE SMILES / InChI

Molecular Formula	C7H8N2O4
Molecular Weight	184.1494
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Ribonucleotide reductase 8 Target ID: CHEMBL3301398 Sources: https://www.ncbi.nlm.nih.gov/pubmed/10989193	Inhibitor 8504

PubMed

Title	Date	PubMed
Trimidox, an inhibitor of ribonucleotide reductase, induces apoptosis and activates caspases in HL-60 promyelocytic leukemia cells.	2000-08	10989193

Substance Class	Chemical Created by `admin` on `Mon Mar 31 19:10:58 GMT 2025` Edited by `admin` on `Mon Mar 31 19:10:58 GMT 2025`
Record UNII	WRR9SR69TE
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

VF-233

Preferred Name

English

3,4,5-TRIHYDROXYBENZAMIDOXIME

Systematic Name

English

N,3,4,5-TETRAHYDROXYBENZIMIDAMIDE

Systematic Name

English

BENZENECARBOXIMIDAMIDE, N,3,4,5-TETRAHYDROXY-

Systematic Name

English

N,3,4,5-TETRAHYDROXYBENZENECARBOXIMIDAMIDE

Systematic Name

English

TRIMIDOX

Common Name

English

Code System Code Type Description

EPA CompTox

DTXSID40914733

Created by admin on Mon Mar 31 19:10:58 GMT 2025 , Edited by admin on Mon Mar 31 19:10:58 GMT 2025

PRIMARY

FDA UNII

WRR9SR69TE

Created by admin on Mon Mar 31 19:10:58 GMT 2025 , Edited by admin on Mon Mar 31 19:10:58 GMT 2025

PRIMARY

CAS

95933-74-7

Created by admin on Mon Mar 31 19:10:58 GMT 2025 , Edited by admin on Mon Mar 31 19:10:58 GMT 2025

PRIMARY

PUBCHEM

5464467

Created by admin on Mon Mar 31 19:10:58 GMT 2025 , Edited by admin on Mon Mar 31 19:10:58 GMT 2025

PRIMARY